Assistance from an artificial intelligence (AI) algorithm with high diagnostic accuracy improved radiologist performance in detecting lung cancers on chest X-rays and increased human acceptance of AI suggestions, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA).
News | Artificial Intelligence
High Accuracy Artificial Intelligence Improves Lung Cancer Detection

June 30, 2023 — Assistance from an artificial intelligence (AI) algorithm with high diagnostic accuracy improved ...

Time June 30, 2023
Home
Jukes Namm, MD, assesses a patient's scan results and is familiar with the 'scanxiety,' many patients feel throughout this process. 
News | Radiology Imaging
Doctors Say Cancer Survivors Experience ‘Scanxiety’ with Screenings

June 30, 2023 — Over 18 million people in the US who have been diagnosed with cancer are cancer survivors, according to ...

Time June 30, 2023
Home
Using an automated deep-learning AI tool, as well as weight-based volumetric thresholds, might afford large-scale evaluation for splenomegaly on CT examinations performed for any indication.
News | Computed Tomography (CT)
AI With Volumetric Thresholds Facilitate Opportunistic Screening for Splenomegaly

June 29, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time June 29, 2023
Home
177Lutetium-labeled radiohybrid (rh) Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1) is an optimized, next generation therapeutic radiopharmaceutical
News | SNMMI
Blue Earth Therapeutics Announces Results of Early Clinical and Preclinical Studies of Investigational 177Lu-rhPSMA-10.1 in Treatment of Prostate Cancer

June 29, 2023 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time June 29, 2023
Home
Digital detectors with proprietary LSO crystals deliver high-resolution imaging
News | PET-CT
Siemens Healthineers Debuts Biograph Vision.X PET/CT Scanner

June 29, 2023 — At the 2023 Annual Meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI), June 24-27 at ...

Time June 29, 2023
Home
ITN SNMMI Article 2 Alz
News | SNMMI
Research Showing Genomics- and Image-Guided Subtyping Refines Characterization of Alzheimer’s Disease Presented at SNMMI 2023

June 29, 2023 — Research presented at the 2023 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging ...

Time June 29, 2023
Home
ITN SNMMI Article 1
News | SNMMI
Prostate Cancer Treatment Study at SNMMI 2023 Finds Improved Patient Outcomes with Personalized Dosing

June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) ...

Time June 29, 2023
Home
The companies’ long-standing collaboration to develop integrated technology helps create better experiences for patients and providers
News | Artificial Intelligence
Nuance and Epic Expand Ambient Documentation Integration Across the Clinical Experience with DAX Express for Epic

June 28, 2023 — Nuance Communications, Inc., a Microsoft Company and Epic announced that they are making the Nuance ...

Time June 28, 2023
Home
The Board of Directors of the Radiological Society of North America (RSNA) announced today that Susanna I. Lee, M.D., Ph.D., has been selected as editor of Radiology Advances
News | RSNA
Susanna I. Lee, MD, PhD, Named Editor of New RSNA Open Access Journal

June 28, 2023 — The Board of Directors of the Radiological Society of North America (RSNA) announced today that Susanna ...

Time June 28, 2023
Home
The integration of its advanced AIR technologies with the SIGNA PET/MR AIR system, to enhance diagnostic precision, simplify treatment evaluation, while elevating patient comfort
News | SNMMI
GE HealthCare Advances PET/MR Capabilities with AIR Technologies

June 28, 2023 — GE HealthCare is set to unveil SIGNA PET/MR AIR[i], at the Society of Nuclear Medicine and Molecular ...

Time June 28, 2023
Home
Molecular imaging with 18F-flubatine PET/MRI has shown that neuroreceptors in the brains of individuals with obesity respond differently to food cues than those in normal-weight individuals, making the neuroreceptors a prime target for obesity treatments and therapy
News | SNMMI
Molecular Imaging Identifies Brain Changes in Response to Food Cues; Offers Insight into Obesity Interventions

June 28, 2023 — Molecular imaging with 18F-flubatine PET/MRI has shown that neuroreceptors in the brains of individuals ...

Time June 28, 2023
Home
A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it a prime candidate for a novel theranostics approach
News | SNMMI
Novel Theranostic Agent Targets Multiple Cancer Types

June 28, 2023 — A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake ...

Time June 28, 2023
Home
A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99Tc-SPECT myocardial perfusion imaging (MPI)
News | SNMMI
Novel Radiotracer Demonstrates High Diagnostic Efficacy for Obese Patients with Coronary Artery Disease

June 28, 2023 — A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese ...

Time June 28, 2023
Home
ITN SNMMI Nadel Stanford image
News | SNMMI
Society of Nuclear Medicine and Molecular Imaging Names Helen Nadel, MD, FRCPC, of Stanford, as President, Announces New Officers at SNMMI 2023 Annual Meeting

June 27, 2023 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at ...

Time June 27, 2023
Home
Contrast-enhanced mammography (CEM) is an emerging modality combining digital mammography with the administration of a contrast agent
News | Contrast Media
FDA approves Bayer’s Ultravist (iopromide) Injection for Contrast-enhanced Mammography

June 26, 2023 — Bayer announced that Ultravist (iopromide)-300, -370, its iodine-based contrast agent, has been approved ...

Time June 26, 2023
Home
Nizar A. Mullani, one of the pioneers of the first positron emission tomography (PET) prototype, has been named as this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award.
News | SNMMI
Nizar A. Mullani Receives SNMMI 2023 Georg Charles de Hevesy Nuclear Pioneer Award

June 26, 2023 — Nizar A. Mullani, one of the pioneers of the first positron emission tomography (PET) prototype, has ...

Time June 26, 2023
Home
Umar Mahmood, MD, PhD, chief of Nuclear Medicine and Molecular Imaging, director of the Center for Precision Imaging, and associate chair for imaging sciences in the Department of Radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School in Boston, Massachusetts, has been named as the first recipient of the new Minoshima-Pappas Transformational Leadership Award.
News | SNMMI
Umar Mahmood, MD, PhD, Receives First Annual SNMMI Minoshima-Pappas Transformational Leadership Award

June 26, 2023 — Umar Mahmood, MD, PhD, chief of Nuclear Medicine and Molecular Imaging, director of the Center for ...

Time June 26, 2023
Home
SNMMI article 2 image
News | SNMMI
Study on Value of 68Ga-FAPI PET/CT Imaging for Evaluation of Disease Activity in Rheumatoid Arthritis presented during SNMMI 2023

June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease ...

Time June 26, 2023
Home
During its 2023 Annual Meeting, the Image of the Year was selected by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and represents research presented which reports on the ability of a novel theranostic pair to successfully detect metastatic pancreatic cancer and provide a means of selecting appropriate treatments.
News | SNMMI
Image of the Year and Research Announced at SNMMI 2023 on Theranostic Pair for Early Detection and Effective Treatment of Pancreatic Cancer

June 26, 2023 — A first-in-human evaluation of the novel theranostic pair 68Ga-DOTA-5G / 177Lu-DOTA-ABM-5G has confirmed ...

Time June 26, 2023
Home
A new PET radiotracer that visualizes the enzyme primarily responsible for metabolic cholesterol degradation in the brain has been successfully validated
News | SNMMI
Translational PET Tracer Visualizes Brain Cholesterol Metabolism

June 25, 2023 — A new PET radiotracer that visualizes the enzyme primarily responsible for metabolic cholesterol ...

Time June 25, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now